Sandra J. Gunselman
Chief Executive Officer at Mobility Health, Inc.
Profile
Sandra J.
Gunselman is the founder and current President & Chief Executive Officer of Mobility Health, Inc. which is founded in 2020.
She is also currently the Vice President-Laboratory Operations at Assurex Health, Inc. where she started in 2015.
Dr. Gunselman holds a doctorate degree from Colorado State University and an undergraduate degree from Lipscomb University.
Sandra J. Gunselman active positions
Companies | Position | Start |
---|---|---|
Assurex Health, Inc.
Assurex Health, Inc. Pharmaceuticals: MajorHealth Technology AssureRx Health, Inc. operates as a personalized medicine company that develops genetic tests. It specializes in pharmacogenomics, a study of the genetic factors that influence an individual’s response to drug treatments, as well as evidence-based medicine and clinical pharmacology. The firm offers GeneSight, a genetic test that helps healthcare providers to take a personalized approach for prescribing medicine for patients; GeneSight Psychotropic, a test that analyzes genes that affects a patient’s response to antidepressant and antipsychotic medications; and GeneSight Analgesic, a test that analyzes how genes affect the way the body respond to medicines prescribed to treat acute or chronic pain. The company was founded by Donald R. Wright Jr. in 2006 and is headquartered in Mason, OH. | Corporate Officer/Principal | 2015-06-28 |
Mobility Health, Inc. | Chief Executive Officer | 2019-12-31 |
Training of Sandra J. Gunselman
Lipscomb University | Undergraduate Degree |
Colorado State University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Assurex Health, Inc.
Assurex Health, Inc. Pharmaceuticals: MajorHealth Technology AssureRx Health, Inc. operates as a personalized medicine company that develops genetic tests. It specializes in pharmacogenomics, a study of the genetic factors that influence an individual’s response to drug treatments, as well as evidence-based medicine and clinical pharmacology. The firm offers GeneSight, a genetic test that helps healthcare providers to take a personalized approach for prescribing medicine for patients; GeneSight Psychotropic, a test that analyzes genes that affects a patient’s response to antidepressant and antipsychotic medications; and GeneSight Analgesic, a test that analyzes how genes affect the way the body respond to medicines prescribed to treat acute or chronic pain. The company was founded by Donald R. Wright Jr. in 2006 and is headquartered in Mason, OH. | Health Technology |
Mobility Health, Inc. |
- Stock Market
- Insiders
- Sandra J. Gunselman